Furthermore, CBS mRNA level was significantly decreased in tumors (N=406) compared to adjacent normal tissues (N=211) in gastric cancer patients (Figure 6B), consistent with the hypothesis that CBS is a tumor suppressor in gastric cancers characterized by PI3K/AKT/mTORC1 pathway alterations. This evidence concerns the gene CBS and gastric cancer.